NK cell expression of Tim-3: First impressions matter

Area of Science:

• Immunology
• Cancer Biology
• Cellular Signaling

Background:

• Co-signaling molecules on NK cells are crucial targets for cancer immunotherapy.
• The role of T-cell immunoglobulin and mucin-containing domain (Tim)-3 in NK cell responses to antibody-decorated tumors is not fully understood.

Purpose of the Study:

• To investigate how tumors treated with therapeutic monoclonal antibodies (mAbs) affect co-signaling molecule expression on human NK cells.
• To determine if Tim-3 upregulation on NK cells signifies exhaustion or a response to diverse stimuli.

Main Methods:

• Stimulation of human NK cells with aggregated IgG1, mAb-opsonized tumors, Fc multimers, and cytokines (IL-12/IL-18).
• Analysis of HAVCR2 (Tim-3) and 4-1BB (CD137) gene and protein expression.
• Assessment of IFN-γ production by Tim-3+ NK cells in response to tumor cells.

Main Results:

• NK cell stimulation by various stimuli, including mAb-opsonized tumors, upregulated Tim-3 (HAVCR2) expression at both gene and protein levels.
• Tim-3 expression increased rapidly (20 minutes) and sustained for hours, distinct from the later 4-1BB (CD137) upregulation (4 hours).
• The functionality of Tim-3+ NK cells, specifically IFN-γ production, was dependent on the stimulus used for Tim-3 induction.

Conclusions:

• Tim-3 upregulation is a common outcome of diverse NK cell activation stimuli, not solely an indicator of NK cell exhaustion.
• The functional plasticity of Tim-3+ NK cells explains their varied roles in anti-tumor immunity.
• Findings necessitate careful consideration of anti-Tim-3 therapies in cancer immunotherapy due to the complex nature of Tim-3 signaling.